Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Mesa Laboratories ( (MLAB) ) has provided an announcement.
On August 22, 2025, Mesa Laboratories held its annual meeting of shareholders where 5,203,377 shares were represented. During the meeting, the election of directors was confirmed, with John J. Sullivan, Gary M. Owens, Jenny S. Alltoft, Shannon M. Hall, Shiraz S. Ladiwala, R. Tony Tripeny, and Mark C. Capone elected to the board for a one-year term. The board also appointed members to its committees. Additionally, the shareholders ratified the selection of Baker Tilly US, LLP as the independent registered public accounting firm for the fiscal year ending March 31, 2026. The compensation of the company’s named executive officers was approved on a non-binding basis, and an amendment to the 2021 Equity Incentive Plan was also approved.
The most recent analyst rating on (MLAB) stock is a Hold with a $69.00 price target. To see the full list of analyst forecasts on Mesa Laboratories stock, see the MLAB Stock Forecast page.
Spark’s Take on MLAB Stock
According to Spark, TipRanks’ AI Analyst, MLAB is a Neutral.
Mesa Laboratories’ stock score is primarily impacted by its mixed financial performance, with strong revenue growth but ongoing profitability challenges. The technical analysis indicates a bearish trend, and the valuation reflects unprofitability. However, the strategic corporate event positively influences the score by demonstrating effective financial management.
To see Spark’s full report on MLAB stock, click here.
More about Mesa Laboratories
Average Trading Volume: 156,648
Technical Sentiment Signal: Sell
Current Market Cap: $401.4M
For detailed information about MLAB stock, go to TipRanks’ Stock Analysis page.